Venovenous ECMO application as bridge to recovery or lung transplantation; ongoing challenge as we look at a pre- and post-COVID-19 era.
Michael M. Koerner, M.D.
Ghodsizad, A., A. Gant, M. M. Koerner and M. Loebe (2021). “Venovenous ECMO application as bridge to recovery or lung transplantation; ongoing challenge as we look at a pre- and post-COVID-19 era.” J Card Surg 36(10): 3747-3748.
Since the coronavirus outbreak (coronavirus SARS‐CoV‐2/Wuhan, China 2019) there have been millions of confirmed cases and deaths worldwide. If we look at new infection and vaccination rates as competing factors, clearly there is an ongoing race between the number of vaccinated individuals and the ability of the virus undergoing new mutations. New virus variants—first described by the geographic location variant found at including “Delta (+),” have again challenged several eastern and middle eastern countries. Observing the current situation in the Middle East the importance of vaccination choice and timing clearly becomes visible.[No abstract; excerpt from article].
